Rutgers Cancer Institute | Strategic Alliance Partners
Latest from Rutgers Cancer Institute
From radiopharmaceuticals to hypofractionated radiation therapy, one expert explained the current landscape of radiation treatments for prostate cancer.
One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma.
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
KTX-1001 Elicits Responses in Some With Multiple Myeloma
3
New Combination Treatment Approach Studied in Pancreatic Cancer
4
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
5